BioCentury
ARTICLE | Company News

Medicyte, Sernova deal

September 16, 2013 7:00 AM UTC

The companies signed a material transfer agreement to jointly evaluate the use of Medicyte's upcyte technology in Sernova's Cell Pouch System to treat hemophilia A. The companies have also signed a non-binding term sheet outlining the general terms of a collaboration for preclinical and clinical development of the combination. Sernova and Medicyte plan to complete negotiations of a definitive agreement while initial research is being conducted under the terms of the material transfer agreement. The companies could not be reached for details. ...